Obesity is one of the most significant public health challenges in the United States, and Montana is no exception. According to the CDC, more than 40% of American adults live with obesity — a chronic condition associated with increased risk of type 2 diabetes, cardiovascular disease, sleep apnea, joint disorders, and certain cancers.
For decades, treatment options were limited to diet, exercise, and surgical intervention. That landscape has changed dramatically with the development of GLP-1 receptor agonist medications. These FDA-approved treatments have demonstrated unprecedented results in clinical trials, offering a new evidence-based path for patients who have struggled with traditional approaches.
PeakHealth MT brings GLP-1 weight loss treatment directly to Montana residents through secure telehealth consultations, eliminating the need to travel to specialty clinics and making medically supervised care accessible from anywhere in the state.
What Are GLP-1 Medications?
GLP-1 (glucagon-like peptide-1) is a naturally occurring hormone produced in the gut after eating. It plays a central role in regulating appetite, blood sugar levels, and energy metabolism. GLP-1 receptor agonist medications mimic this hormone's effects at a therapeutic level, providing powerful support for weight management.
These medications work through several key mechanisms:
- Appetite suppression: GLP-1 medications act on brain receptors that regulate hunger, helping patients feel satisfied with smaller portions and reducing food cravings.
- Slowed gastric emptying: Food moves through the stomach more slowly, prolonging the feeling of fullness after meals and reducing the urge to snack between meals.
- Blood sugar regulation: GLP-1 medications enhance insulin secretion and reduce glucagon release, helping stabilize blood glucose — particularly beneficial for patients with insulin resistance or prediabetes.
- Metabolic improvement: Beyond weight loss, these medications may improve cholesterol levels, blood pressure, and other metabolic markers associated with obesity.
GLP-1 medications are administered as weekly subcutaneous injections using pre-filled pen devices. Dosing follows a gradual titration schedule to optimize effectiveness while minimizing side effects.
Common GLP-1 Medications
Two medications currently lead the GLP-1 category for weight management:
Semaglutide
Semaglutide is a GLP-1 receptor agonist available as Wegovy® (FDA-approved for chronic weight management) and Ozempic® (FDA-approved for type 2 diabetes). It targets the GLP-1 receptor to reduce appetite, slow gastric emptying, and improve blood sugar control.
Learn more about semaglutide weight loss treatment in Montana or visit our Wegovy® in Montana page.
Tirzepatide
Tirzepatide is a dual GIP/GLP-1 receptor agonist available as Zepbound® (FDA-approved for chronic weight management) and Mounjaro® (FDA-approved for type 2 diabetes). By targeting two hormonal pathways simultaneously, tirzepatide may provide enhanced appetite regulation and metabolic support compared to single-target GLP-1 medications.
Learn more about tirzepatide weight loss treatment in Montana or visit our Zepbound® in Montana page.
For a detailed comparison of these two medications, read our semaglutide vs tirzepatide guide.
Expected Weight Loss Results
In clinical trials, participants using GLP-1 medications lost an average of 15–22% of their body weight over 68–72 weeks when combined with lifestyle changes.
Semaglutide (STEP trials): Participants receiving semaglutide 2.4 mg weekly lost an average of approximately 15% of their body weight. For a person weighing 250 pounds, that represents roughly 37 pounds of weight loss.
Tirzepatide (SURMOUNT trials): Participants receiving the highest dose of tirzepatide lost an average of approximately 22.5% of their body weight. For the same 250-pound individual, that represents roughly 56 pounds. More than one-third of participants in the highest-dose group lost 25% or more of their body weight.
Individual results vary based on starting weight, medication adherence, dietary changes, physical activity, and underlying health conditions. Most patients begin to see meaningful changes within the first 8–12 weeks, with continued progress over the following months as doses are gradually titrated upward.
Your clinician will set realistic, personalized goals during your consultation based on your medical history and health objectives.
Why Many Montana Patients Choose Telehealth Weight Loss Care
Montana is the fourth-largest state by area, with a population spread across vast distances. Many residents live an hour or more from the nearest medical facility — and even longer from a provider who specializes in medical weight management. Telehealth solves this access problem.
- No travel required: Attend appointments from your home, office, or anywhere with a reliable internet connection — no driving hours to a clinic.
- Rural access: Patients in smaller and more remote communities receive the same quality of clinician-led care as those in Billings, Missoula, or Bozeman.
- Flexible scheduling: Appointment times that work around your job, family responsibilities, and daily life.
- Privacy: Discuss your weight loss goals in a comfortable, private setting through a secure, HIPAA-compliant platform.
- Continuity of care: Regular follow-up visits maintain consistent clinician oversight throughout your treatment.
For many Montana patients, telehealth isn't just convenient — it's the difference between receiving specialized medical weight loss care and going without.
How the PeakHealth MT Program Works
PeakHealth MT provides a structured, clinician-led weight loss program built around individualized care. Here's how the process works:
- Schedule your consultation. Book a secure video visit online. Onboarding is a one-time $25 and includes a comprehensive medical evaluation.
- Complete your medical review. Your clinician reviews your health history, current medications, and baseline laboratory results. Labs can be completed at local facilities such as Labcorp or Quest Diagnostics.
- Individualized plan. If prescription treatment is clinically appropriate, the clinician may send a prescription for the GLP-1 medication best suited to your needs to your chosen pharmacy. A prescription is never guaranteed.
- Ongoing monitoring and follow-up. The PeakHealth monthly subscription ($99/mo) are scheduled regularly to track your progress, adjust dosing through gradual titration, manage side effects, and ensure your treatment plan stays on course.
All treatment plans are prescribed and monitored by Wesley Hardin, PA-C, with over 15 years of clinical experience in primary care — focused on long-term metabolic health, appetite regulation, and sustainable weight management.
Learn more about how our telehealth process works or review our transparent pricing.
Cities Served Across Montana
PeakHealth MT provides GLP-1 weight loss treatment to patients throughout Montana via secure telemedicine. We serve residents in the following communities and surrounding areas:
- Billings
- Bozeman
- Missoula
- Helena
- Great Falls
- Kalispell
- Butte
- Whitefish
- Livingston
- Laurel
- Havre
- Miles City
- Sidney
- Glendive
Don't see your community listed? PeakHealth MT serves all Montana residents through telemedicine. No matter where you are in the state, you can access the same high-quality, clinician-led care.
Start Your Consultation
If you're a Montana resident considering GLP-1 medication for weight loss, PeakHealth MT is here to help. Our approach is built on individualized, clinician-led care — every patient receives a thorough medical evaluation, lab review, and a treatment plan tailored to their specific needs and goals.
Sustainable weight loss is a long-term commitment that requires ongoing clinical management. At PeakHealth MT, you won't just receive a prescription — you'll have a dedicated clinician guiding your progress every step of the way.
Ready to find out if GLP-1 treatment is right for you? Schedule your online consultation today.
